医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

A Technology Project of Beijing Handian Pharmaceutical: Honee Taishen Granule for COVID-19

2020年06月28日 PM12:18
このエントリーをはてなブックマークに追加


 

BEIJING

The research team of Handian Pharmaceutical Medical Center and Handian Traditional Chinese Medicine Hospital has devoted to develop a new formula against COVID-19, which in traditional Chinese medicine theory, is differentiated as cold-dampness viral disease with the symptoms of fever, aversion to cold, cough, fatigue, general aching pain, headache, diarrhea, etc. After several months of hardworking, they initially developed Honee Taishen Granule (also known as Handian HD1). Cooperating with Chinese Academy of Medical Sciences and Good Laboratory Practice (GLP) certification agencies, Handian Pharmaceutical Medical Center has completed pharmacy studies. Pharmacology and toxicology tests are still in progress to further evaluate its safety and efficacy.

This formula is derived from a famous traditional Chinese medicine prescription. Its components can eliminate dampness and turbidity, repel foulness and remove toxin, which give it cold-dampness eliminating and antiviral effects. According to traditional Chinese medicine theory, it rectifies taiyin cold damp constitution and restores yin-yang balance of the body, which can help patients regain immunity and prevents the virus from affecting the spleen (pancreas) to damage the body.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200627005012/en/

CONTACT

For more information, please contact:

Xiaoteng Bai

Branding and strategy Manager

Beijing Handian Science & Technology (Group) Co., Ltd.

Email: Baixiaoteng@handian.com

Phone: +86 010 5690 3502

Website: http://www.hantien.com.cn/

同じカテゴリーの記事 

  • ACC Moving to Cloud on the FINEOS Platform
  • Zai Lab-Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers, Including Through Combination PARP Inhibitor and CCR8 Therapy
  • ザイード・サステナビリティ賞は5,900件を超える応募があり、世界的な広がりと影響力を実証しています
  • 扎耶德可持续发展奖展示全球影响力,收到超过5,900份申请
  • Poxel Provides an Update on Its Financial Position for the Second Quarter and First Half of 2024 and Announces the Rescheduling of Its Annual General Meeting